Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$520,979,205
+$122,980,783 QoQ
Shares Held
2,411,271
+11.1% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. BIIB ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,979,205 | 2,411,271 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $397,998,422 | 2,170,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $409,179,030 | 2,325,013 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $315,395,014 | 2,251,535 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $245,680,404 | 1,956,210 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $272,403,001 | 1,990,668 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $272,557,868 | 1,782,356 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $365,823,752 | 1,887,246 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $372,420,675 | 1,606,508 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $366,869,207 | 1,701,383 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $408,281,344 | 1,577,777 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $383,744,963 | 1,493,113 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $407,705,512 | 1,431,299 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $363,065,746 | 1,305,851 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $394,006,200 | 1,422,816 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $331,828,668 | 1,242,804 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $280,812,119 | 1,376,935 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $201,297,583 | 955,829 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $187,252,756 | 780,480 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $213,293,802 | 753,715 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $243,142,131 | 702,175 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $172,825,910 | 617,787 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $190,379,380 | 777,503 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $196,702,856 | 693,397 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $100,790,363 | 376,716 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $117,665,829 | 371,913 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||